Daniel Corey
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel Corey
Daniel Corey is recorded as Board Member and CTO at Cero Therapeutics Holdings, Inc. (CERO). Cero Therapeutics Holdings, Inc. reported in an 8-K filed September 25, 2024 that Daniel Corey resigned as Chief Technology Officer. Cero Therapeutics Holdings, Inc. reported in an 8-K filed September 25, 2024 that Daniel Corey resigned as board seat. Cero Therapeutics Holdings, Inc. reported in an 8-K filed September 25, 2024 that Daniel Corey resigned as director, effective September 23, 2024. Equibles holds 6 filed executive changes naming Daniel Corey; each is listed under recent activity with its source filing. The proxy statement of Cero Therapeutics Holdings, Inc. reports total compensation of $1,073,213 for Daniel Corey in fiscal 2024, including a base salary of $263,750. Disclosed compensation is on record for 3 fiscal years.
“Both Charles Carter, CERo’s Chief Financial Officer, and Daniel Corey, M.D., Chief Technology Officer have also elected to step down from their positions and board seat in the case of Dr. Corey.”
“Both Charles Carter, CERo’s Chief Financial Officer, and Daniel Corey, M.D., Chief Technology Officer have also elected to step down from their positions and board seat in the case of Dr. Corey.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-02-15–present
-
Current
2024-02-14–present
-
Start not stated–2024-09-23
-
Start not stated–2024-09-23
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cero Therapeutics Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian G. Atwood CEO, Chairman
- Chris Ehrlich CEO, Chairman, Board Member
- Andrew Albert "Al" Kucharchuk CFO
- Andrew Albert Kucharchuk CFO
- Andrew Albert “Al” Kucharchuk CFO
- Charles Carter CFO
- Eric Francois Board Member
- Lindsey Rolfe Board Member
- Lindsey Rolfe, M.D. Board Member
- Michael Byrnes Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Cero Therapeutics Holdings, Inc. (CERO) | Former Chief Technology Officer and Former Chief Executive Officer | $263,750 | $1,073,213 |
| 2023 | Cero Therapeutics Holdings, Inc. (CERO) | Former Chief Technology Officer and Former Chief Executive Officer | $360,000 | $376,035 |
| 2022 | Cero Therapeutics Holdings, Inc. (CERO) | Chief Technology Officer and Former Chief Executive Officer | $360,000 | $372,685 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.